- Title
- Current fluconazole treatment regimens result in under-dosing of critically ill adults during early therapy
- Creator
- Sandaradura, Indy; Marriott, Deborah J. E.; Day, Richard O.; Norris, Ross L. G.; Pang, Edna; Stocker, Sophie L.; Reuter, Stephanie E.
- Relation
- European Journal of Clinical Microbiology and Infectious Diseases Vol. 40, Issue 7, p. 1521-1528
- Publisher Link
- http://dx.doi.org/10.1007/s10096-021-04201-w
- Publisher
- Springer
- Resource Type
- journal article
- Date
- 2021
- Description
- Purpose: To evaluate current fluconazole treatment regimens in critically ill adults over the typical treatment course. Methods: Data from critically ill adults treated with fluconazole (n=30) were used to develop a population pharmacokinetic model. Probability of target attainment (PTA) (fAUC24/MIC >100) was determined from simulations for four previously proposed treatment regimens: (i) 400 mg once daily, (ii) an 800 mg loading dose followed by 400 mg once daily, (iii) 400 mg twice daily, and (iv) a 12 mg/kg loading dose followed by 6 mg/kg once daily. The effect of body weight (40, 70, 120 kg) and renal function (continuous renal replacement therapy (CRRT); 20, 60, 120, 180 mL/min creatinine clearance) on PTA was assessed. Results: Early (0–48 h) fluconazole target attainment for infections with a minimum inhibitory concentration (MIC) of 2 mg/L was highly variable. PTA was highest with an 800 mg loading dose for underweight (40 kg) patients and with a 12 mg/kg loading dose for the remainder. End-of-treatment PTA was highest with the 400 mg twice daily maintenance dosing for patients who were under- or normal weight and 6 mg/kg maintenance dosing for overweight (120 kg) patients. None of the fluconazole regimens reliably attained early targets for MICs of ≥4 mg/L. Conclusion: Current fluconazole dosing regimens do not achieve adequate early target attainment in critically ill adults, particularly in those who are overweight, have higher creatinine clearance, or are undergoing CRRT. Current fluconazole dosing strategies are generally inadequate to treat organisms with an MIC of ≥4 mg/L.
- Subject
- fluconazole; population pharmacokinetics; target attainment; critical illness
- Identifier
- http://hdl.handle.net/1959.13/1474946
- Identifier
- uon:49423
- Identifier
- ISSN:0934-9723
- Language
- eng
- Reviewed
- Hits: 961
- Visitors: 960
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|